Podchaser Logo
Home
Developing Multiple Vaccines Against COVID-19  Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals

Developing Multiple Vaccines Against COVID-19 Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals

Released Wednesday, 1st July 2020
Good episode? Give it some love!
Developing Multiple Vaccines Against COVID-19  Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals

Developing Multiple Vaccines Against COVID-19 Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals

Developing Multiple Vaccines Against COVID-19  Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals

Developing Multiple Vaccines Against COVID-19 Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals

Wednesday, 1st July 2020
Good episode? Give it some love!
Rate Episode

Seth Lederman, MD, Chief Executive Officer and Founder, Tonix Pharmaceuticals brings us up to speed on the work at Tonix in developing new COVID-19 vaccines based on their live, synthetic horsepox vector system with a focus on vaccinating the subgroup of healthy people who are not pregnant and have a working immune system. Seth talks about the advantages of using live replicating virus vaccines as well as how immuno-oncology is informing their approach to stimulating T-cells to fight infectious diseases. In addition, new medicines are being developed to treat fibromyalgia and PTSD.

@TonixPharma

#COVID19 #vaccines #PTSD #fibromyalgia #pain

TonixPharma.com

Download the transcript here

Tonix

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features